Innovative Biotechnology Focus Ukko is leveraging cutting-edge immunology, computational biology, and plant science technologies to address food allergies, positioning it as a pioneer in personalized and health-focused food solutions. This innovative approach presents opportunities to collaborate with food manufacturers and healthcare providers seeking advanced allergy management.
Strong Funding & Growth Potential With a recent $40M Series B funding round led by Bayer’s Leaps by Bayer, Ukko demonstrates significant investor confidence and financial stability, making it a promising partner for joint research, licensing, or technology licensing opportunities in biotech and health sectors.
Global Presence & Collaboration Having offices in Tel Aviv and Palo Alto, Ukko is well-positioned to foster international partnerships, access cutting-edge research ecosystems, and expand into North American and European markets, opening avenues for joint ventures and strategic alliances.
Technology-Driven Solutions Ukko’s utilization of advanced AI, protein engineering, and cloud technologies indicates their openness to integrating with technology providers for data analytics, AI solutions, and biotech software, offering potential for SaaS or platform partnership opportunities.
Market Expansion & Industry Position Positioned within the biotech industry with a focus on food allergies, Ukko is aligned with growing consumer demand for healthier and allergy-friendly foods, making it a target for market expansion initiatives, distribution partnerships, and product development collaborations with food and health companies.
$1B$10B
$1M$10M
$1B$10B
$10B
$10B
$1B$10B
$1B$10B
$1B$10BUkko uses 8 technology products and services including Google Analytics Enhanced eCommerce, Fastly, WordPress, and more. Explore Ukko's tech stack below.
| Ukko Email Formats | Percentage |
| First@ukko.us | 50% |
| First@ukko.us | 50% |
Biotechnology ResearchIsrael51-200 Employees
Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California.
Company Overview
Funding & FinancialsUkko has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2021 in the amount of $40M.
Ukko's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsUkko has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2021 in the amount of $40M.
Ukko's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com